Meet Phillips Medisize at PDA Universe 2026
Phillips Medisize looks forward to connecting with pharmaceutical leaders at PDA Universe of Pre-Filled Syringes and Injection Devices Conference, October 6–7, 2026.
Featured Presentation
Tony Bedford, Director of Global Innovation & Development at Phillips Medisize, will co-present “The Science, Engineering and Commercialization of Subcutaneous High Dose Drug Delivery” on Wednesday, October 7 at 1:35-1:55pm PDT.
This presentation brings together two complementary viewpoints to outline the current scientific knowledge, recent engineering advances and commercial realities of enabling reliable high-dose administration. Key topics include high-force devices, fast-rate delivery, pain and discomfort, and primary packaging.
Note: this is a co-presentation by Crux and Phillips Medisize based on experience in developing and commercializing drug delivery device technology.
Visit Us
You’ll find us at Booth 800 area. Stop by to learn how Phillips Medisize helps bring drug-device combination products from concept to commercialization, across both parenteral and inhalation delivery routes.
With decades of experience in parenteral and inhalation drug delivery solutions, Phillips Medisize provides integrated capabilities that span the entire product lifecycle, from formulation, early feasibility and device innovation through industrialization, regulatory support and high-volume manufacturing. We can help accelerate your path to market while reducing complexity and risk.
Arrange a Meeting
Planning to attend PDA Universe? Schedule time with our team to discuss your program goals, technical challenges, and commercialization strategy. We welcome both pre-show inquiries and meetings during the event and look forward to exploring how we can help advance your next drug delivery innovation. Contact us today!